From NIH National Cancer Institute Web Sites
- Approaches to Blue Ribbon Panel Recommendations: The Case of Lynch Syndrome
- Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options
- Aspirin to Reduce Cancer Risk
- Bringing Precision to Screening for Cancer
- Cancer Control P.L.A.N.E.T. portal
Cancer Control P.L.A.N.E.T. portal provides access to data and resources that can help planners, program staff, and researchers design, implement and evaluate evidence-based cancer control programs. - Cancer Moonshot Blue Ribbon Panel Report
- Cancer Moonshot℠
- CCG Funding Opportunities
Biospecimen Processing and Storage - Checking In on Cancer Checkpoint Inhibitors
- Divide and Conquer: The Molecular Diagnosis of Cancer
- DNA Misfolding Revealed as Novel Oncogenic Mechanism
- Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches
- Establishing UniversalLynch Syndrome Screening in the Community
- FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer
- For Some Children with Cancer, Genomic Information May Help Guide Treatment Decisions
- Gene Fusion May Drive Rare Childhood Brain Tumor
- Genetics of Skin Cancer (PDQ®)Health Professional Version
- How Genomics Is Shaping Precision Medicine in Oncology
- Insights from the Precision Public Health Summit
- Kidney (Renal Cell) CancerPatient Version
- Metabolomics in Population-Based Research
- NCI-DOE Collaboration Paving Way for Large-Scale Computational Cancer Science
- NCI-MATCH: A Status Report and Future Directions
- Precision Medicine and Population Health
Cross Cutting Research Area in the NCI Division of Cancer Control and Population Sciences - Prevention and Early Detection for Hereditary Cancer Syndromes
NCI website with resources, events and funding - Researchers report initial feasibility of identifying patients who are exceptional responders to cancer therapy
- Stomach (Gastric) Cancer Prevention (PDQ®)Health Professional Version
- Targeted Photoimmunotherapy Approach for Cancer Moves Forward
- The Cancer Genome Atlas
- Thyroid CancerPatient Version
- Using Gene Expression to Diagnose Lung Cancer More Accurately
- With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung Cancer
No hay comentarios:
Publicar un comentario